Literature DB >> 33472979

The temporary ban on tobacco sales in South Africa: lessons for endgame strategies.

Samantha Filby1, Kirsten van der Zee2, Corné van Walbeek2.   

Abstract

BACKGROUND: The endgame literature recommends that, for a tobacco sales ban to be successful, several demand-side preconditions (eg, low prevalence and effective cessation support) should be in place. The South African Government imposed a ban on the sale of all tobacco and vaping products between 27 March and 17 August 2020, as part of the COVID-19 lockdown.
OBJECTIVES: To assess how cigarette smokers responded to the sales ban, to evaluate how the ban impacted the cigarette market in South Africa and to use the South African experience to inform endgame planning.
METHODS: Regular preban cigarette smokers completed an online questionnaire from 4 to 19 June 2020 (n=23 631), in which they reported on their prelockdown cigarette smoking patterns, quitting behaviour (if relevant) and smoking behaviour during the ban.
RESULTS: About 9% of prelockdown smokers in the sample successfully quit smoking. 93% of continuing smokers purchased cigarettes despite the sales ban. The average price of cigarettes increased by 250% relative to prelockdown prices. Most respondents purchased cigarettes through informal channels.
CONCLUSIONS: The demand-side preconditions for an effective sales ban were not in place in South Africa, making a sales ban inappropriate. The South African experience suggests that supply-side factors are also important in ensuring the success of a sales ban. These are: (1) the illicit market must be under control before implementing a sales ban; and (2) an effective sales ban needs to be synchronised with a ban on the manufacture, transport and distribution of cigarettes. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  economics; end game; illegal tobacco products; public policy

Mesh:

Year:  2021        PMID: 33472979     DOI: 10.1136/tobaccocontrol-2020-056209

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   6.953


  8 in total

1.  Retail endgame strategies: reduce tobacco availability and visibility and promote health equity.

Authors:  Amanda Y Kong; Lisa Henriksen
Journal:  Tob Control       Date:  2022-03       Impact factor: 7.552

2.  Estimating the price elasticity of demand for cigarettes in South Africa using the Deaton approach.

Authors:  Chengetai Dare; Micheal Kofi Boachie; Ernest Ngeh Tingum; S M Abdullah; Corné van Walbeek
Journal:  BMJ Open       Date:  2021-12-17       Impact factor: 2.692

3.  When Cigarette Sales Suddenly Become Illegal: Evidence From an Online Survey of South African Smokers During COVID-19 Lockdown.

Authors:  Kirsten van der Zee; Samantha Filby; Corné van Walbeek
Journal:  Nicotine Tob Res       Date:  2022-05-02       Impact factor: 5.825

Review 4.  Addressing the Needs of People with Schizophrenia in South Africa During the COVID-19 Pandemic.

Authors:  Lindokuhle Thela; Mvuyiso Talatala; Bonginkosi Chiliza
Journal:  Schizophr Bull Open       Date:  2022-07-21

5.  The Impact of the COVID-19 Pandemic on Smoking Consumption: A Systematic Review of Longitudinal Studies.

Authors:  Nerea Almeda; Irene Gómez-Gómez
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

6.  Smoking cessation among people with mental illness: A South African perspective.

Authors:  Tejil Morar; Lesley Robertson
Journal:  S Afr Fam Pract (2004)       Date:  2022-08-30

7.  Drawing on Adolescent Psychology to Achieve Tobacco-Free Generations.

Authors:  Jon Berrick
Journal:  Public Health Rev       Date:  2022-08-04

8.  Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa's COVID-19 Sales Bans: A Case Series.

Authors:  Bronwyn Myers; Tara Carney; Jennifer Rooney; Samantha Malatesta; Laura F White; Charles D H Parry; Tara C Bouton; Elizabeth J Ragan; Charles Robert Horsburgh; Robin M Warren; Karen R Jacobson
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.